MRNA - Moderna, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/2016
Total Revenue135,068205,825108,396
Cost of Revenue454,082410,459274,717
Gross Profit-319,014-204,634-166,321
Operating Expenses
Research Development---
Selling General and Administrative94,25264,72257,450
Non Recurring---
Others---
Total Operating Expenses548,334475,181332,167
Operating Income or Loss-413,266-269,356-223,771
Income from Continuing Operations
Total Other Income/Expenses Net28,85813,3608,603
Earnings Before Interest and Taxes-413,266-269,356-223,771
Interest Expense-3,096-132-139
Income Before Tax-384,408-255,996-215,168
Income Tax Expense326-801,043
Minority Interest---
Net Income From Continuing Ops-384,734-255,916-216,211
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-384,734-255,916-216,211
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-401,857-269,841-230,314